Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs

Canadian Veterinary Journal

Volumn 39, Issue 12, 1998, Pages 753-756

  Scott, Danny W ^a   Beningo, Karyn E ^a   Miller Jr , William H ^a   Rothstein, Emily ^a  

^a Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMAZINE; ENROFLOXACIN; ERYTHROMYCIN; SULFADIMETHOXINE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; DOG; DRUG EFFICACY; DRUG SAFETY; EXPERIMENTAL INFECTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PYODERMA; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS INTERMEDIUS; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, ORAL; AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DOG DISEASES; DOGS; FEMALE; MALE; PYODERMA; STAPHYLOCOCCAL INFECTIONS;

EID: 0032411424     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Scott DW, Miller WH Jr, Griffin CE. Muller & Kirk's Small Animal Dermatology V. Philadelphia: WB Saunders, 1995.
2. Burrows GE. Pharmacotherapeutics of macrolides, lincomycins. and spectinomycin. J Am Vet Med Assoc 1980; 176: 1072-1077.
3. Harari J, Lincoln J. Pharmacologic features of clindamycin in dogs and cats. J Am Vet Med Assoc 1989; 195: 124-125.
4. Dow SW, Papich MG. An update on antimicrobials: new uses, modifications, and developments. Vet Med 1991; 86: 707-715.
5. McEvoy GK, ed. AHFS Drug Information 97. Bethesda: American Society of Hospital Pharmacists, 1997: 388-394.
6. Tulkens PM. Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections. Scand J Infect Dis 1991; 74: 209-217.
7. Carbon C. Clinical relevance of intracellular and extracellular concentrations of macrolides. Infection 1995; 23(suppl 1): S10-S14.
8. Ihrke PJ, Halliwell REW, Deuber MJ. Canine pyoderma. In: Kirk RW, ed. Current Veterinary Therapy VI. Philadelphia: WB Saunders 1977: 513-519.
9. Phillips WE Jr., Williams BJ. Antimicrobial susceptibility patterns of canine Staphylococcus intermedius isolates from veterinary clinical specimens. Am J Vet Res 1984; 45: 2376-2379.
10. Rhoades HE. Sensitivity of bacteria to 16 antibiotic agents. Vet Med Small Animal Clin 1979; 74: 976-979.
11. Cox HU, Hoskins JD, Roy AF, Newman SS, Luther DG. Antimicrobial susceptibility of coagulase-positive staphylococci isolated from Louisiana dogs. Am J Vet Res 1984; 45: 2039-2042.
12. Medleau L, Long RE, Brown J, Miller WH. Frequency and antimicrobial susceptibility of staphylococcal species isolated from canine pyoderma. Am J Vet Res 1986; 47: 229-231.
13. Junttila J, Schildt R, Hintikka EL. Koiran ihotulehduksistra eristettyjen stafylokokken herkkyys mikrobilääkkeille. Suomen Eläin 1987; 93: 263-267.
14. Lloyd D. Dealing with cutaneous staphylococcal infection in dogs. In Practice 1996; 18: 223-231.
15. Mason IS. Antibacterial strategies. In: Locke PH, Harvey RG, Mason IS, eds. Manual of Small Animal Dermatology. Shurdington: British Small Animal Veterinary Association, 1993: 213-219.
16. Engrall A, Wherup M. Antibiogram and production of β-lactamase by canine isolates of Staphylococcus aureus. Nord Vet Med 1982; 34: 44-48.
17. Cardini G, Mengozzi G, Bianchi L. Le piodermiti del cane: aspetti clinici e terapeutici. Pisa Univ Fac Med Vet Ann 1977; 30: 340-348.
18. Briggs OM. Practical small animal dermatology III: bacterial disease. J S Afr Vet Assoc 1988; 59: 169-172.
19. Devriese L. Antibiotic sensitivity and resistance of Staphylococcus intermedius strains isolated from dogs in Belgium. Diergeneeskd Tijdschr 1988; 57: 40-45.
20. Bevier DE. Canine staphylococcal pyoderma. Choosing the appropriate antibiotic. Vet Med Rep 1990; 2: 288-291.
21. Moriello K, Mason I. Handbook of Small Animal Dermatology. New York: Elsevier Science, 1995: 290.
22. Kwochka KW. Recurrent pyoderma. In: Griffin CE, Kwochka KW, MacDonald JM, eds. Current Veterinary Dermatology. St. Louis: Mosby - Yearbook, 1993: 3-21.
23. Harvey RG, Noble WC, Ferguson EA. A comparison of lincomycin hydrochloride and clindamycin hydrochloride in the treatment of superficial pyoderma in dogs. Vet Rec 1993; 132: 351-353.
24. Littlewood JD, Paterson S, Wood JLN, Lakhani K. Clindamycin hydrochloride and clavulanated amoxicillin in the treatment of superficial pyoderma in dogs. Proc World Small Anim Vet Assoc 1996: 21, 418.
25. Berg JN, Scalan CM, Buening GM, et al. Clinical models for anaerobic bacterial infections in dogs and their use in testing the efficacy of clindamycin and lincomycin. Am J Vet Res 1992. 1984; 45: 1299-1306.
26. Budsberg SL, Kemp DT, Wolski N. Pharmacokinetics of clindamycin phosphate in dogs after single intravenous and intramuscular administration. Am J Vet Res 1992; 53: 2333-2336.
27. Weber DJ, Barbiers AR, Allinger AJ, Neff AW, Pope DG. Pharmacokinetics of clindamycin following subcutaneous administration of clindamycin phosphate in the canine. J Vet Pharmacol Ther 1980; 3: 133-143.
28. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically III. Villanova: National Committee for Clinical Laboratory Standards Document M7-A3, 1993: 13-16.
29. Paradis M, Lemay S, Scott DW. Efficacy of enrofloxacin in the treatment of canine bacterial pyoderma. Vet Dermatol 1990; 1: 123-127.
30. Scott DW, Miller WH Jr, Wellington JR. The combination of ormetoprim and sulfadimethoxine in the treatment of pyoderma due to Staphylococcus intermedium infection in dogs. Canine Pract 1993; 18: 29-33.
31. Scott DW, Miller WH Jr, Cayatte SM, Bagladi MS. Efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedium infection in dogs. Can Vet J 1994; 35: 617-621.
32. Carlotti D, Ovaert P. Utilisation de l'association amoxycilline-acide clavulanique dans le traitement de pyodermites du chien. Prat Méd Chir Anim Comp 1988; 23: 519-522.
33. Angarano DW, MacDonald JM. Efficacy of cefadroxil in the treatment of bacterial dermatitis in dogs. J Am Vet Med Assoc 1989; 194: 57-59.
34. Guaguère E, Marc JP. Utilisation de la céfalexine dans le traitement des pyodermites. Prat Méd Chir Anim Comp 1989; 24: 124-129.
35. Arrioja-Dechert A, ed. Compendium of Veterinary Products IV. Port Huron: North American Compendiums, 1997: 161-162.
36. Greenwood D. In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance. J Infect Dis 1981; 144: 380-385.
37. Leutnek AL. Antimicrobial susceptibility testing. Learning to live with uncertainty. Int J Dermatol 1984; 18: 187-189.
38. Wegener HC, Pedersen K. Variations in antibiograms and plasmid profiles among multiple isolates of Staphylococcus intermedius from pyodermas in dogs. Acta Vet Scand 1992; 33: 391-394.